BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
426 results:

  • 1. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
    Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis.
    Yamada K; Takeuchi M; Fukumoto T; Suzuki M; Kato A; Mizuki Y; Yamada N; Kaneko T; Mizuki N; Horita N
    Sci Rep; 2024 Apr; 14(1):7887. PubMed ID: 38570507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
    Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of cancer in relatives of patients with myelodysplastic neoplasia and acute leukemias.
    Nitschke NJ; Rostgaard K; Andersen MK; Hjalgrim H; Grønbæk K
    Cancer Epidemiol; 2024 Feb; 88():102523. PubMed ID: 38198910
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence and Prognostic Role of Lymphedema in Patients with Deep Venous Thrombosis and Thrombophlebitis.
    Grigorean A; Lindenblatt N; Luchsinger I; Hobohm L; Konstantinides SV; Münzel T; Barco S; Keller K
    Lymphat Res Biol; 2024 Feb; 22(1):20-26. PubMed ID: 38029369
    [No Abstract]    [Full Text] [Related]  

  • 6. Increase in the Life Expectancy of Patients with cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia.
    Lorentzian AC; Rever J; Ergin EK; Guo M; Akella NM; Rolf N; James Lim C; Reid GSD; Maxwell CA; Lange PF
    Nat Commun; 2023 Nov; 14(1):7161. PubMed ID: 37989729
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast cancer Metastasis Inhibition.
    Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of neoadjuvant chemotherapy on surgical outcomes following autologous and implant-based immediate breast reconstruction: A systematic review and meta-analysis.
    Sabitovic A; Trøstrup H; Damsgaard TE
    J Plast Reconstr Aesthet Surg; 2023 Dec; 87():17-23. PubMed ID: 37804643
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between sun-protective behaviors and hypertension: a cross-sectional study from National Health and Nutrition Examination Survey 2009 to 2014.
    Yang S; Dai F; Wang Z; Li R; Xu X; Li C; Hou X; Liu Y; Wang C; Li D; Li L; Xu T
    BMC Public Health; 2023 Sep; 23(1):1862. PubMed ID: 37752456
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiple Myeloma in Adolescent and Young Adults: An ASCO cancerLinQ and SEER Analysis.
    Gibson S; Thornton J; Sunderland K; Pham K; DeStefano C
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e335-e340. PubMed ID: 37541820
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
    Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
    Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rash with different types of bcr-ABL inhibitors in chronic myelogenous leukemia: a systematic review and meta-analysis.
    Li S; Wang T; Zhong Y; Dai S
    Future Oncol; 2023 Jun; 19(17):1215-1227. PubMed ID: 37368411
    [No Abstract]    [Full Text] [Related]  

  • 14. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Significant Association of Cutavirus With Parapsoriasis en Plaques: High Prevalence Both in skin Swab and Biopsy Samples.
    Mohanraj U; Konttinen T; Salava A; Väkevä L; Ranki A; Söderlund-Venermo M
    Clin Infect Dis; 2023 Oct; 77(7):987-990. PubMed ID: 37234048
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results.
    Kantarjian H; Short NJ; Jain N; Sasaki K; Huang X; Haddad FG; Khouri I; DiNardo CD; Pemmaraju N; Wierda W; Garcia-Manero G; Kebriaei P; Garris R; Loghavi S; Jorgensen J; Kwari M; O'Brien S; Ravandi F; Jabbour E
    Am J Hematol; 2023 Mar; 98(3):493-501. PubMed ID: 36600670
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Blastic plasmacytoid dendritic cell neoplasm: a diagnosis not to be missed, about three case reports.
    Fakhfakh Y; Ben Aribia N; Mnif S; Sannenna H; Mnif H; Louati N
    Tunis Med; 2022; 100(8-9):647-651. PubMed ID: 36571733
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Necroptosis-Related Gene Signature to Predict the Prognosis of skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells.
    Tabolacci C; Giordano D; Rossi S; Cordella M; D'Arcangelo D; Moschella F; D'Atri S; Biffoni M; Facchiano A; Facchiano F
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431901
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Concomitant Use of Ado-trastuzumab Emtansine and Imatinib in a Patient of cml and Metastatic Breast cancer.
    Karacin C; Bilgetekin I; Basal FB; Oksuzoglu OB
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1501-1502. PubMed ID: 36377026
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.